The sixth spin-off company – TCI sp.z o.o. has started operating at the University of Gdańsk. It was founded to commercialize innovative ideas and technologies developed at the university in the field of new medical products and medicines.

The company’s task will be to refine the formulation of medical and medicinal preparations, to conduct stability tests and to assure commercial use of new medical products developed at the university including their registration and commercialization. The spin-off company’s activity will enable scientists to carry out the next stages of research and their practical application.

The team of TCI sp. Z o. O. uses the experience gained during scientific work in creating innovative solutions within the biotechnology and biopharmaceutical sectors. The company joined the group of already operating entities: Fermentum Mobile, Qsar Lab, Officina Baltica, Vaxican, NanoExpo.